Ifp Advisors, Inc Guardant Health, Inc. Transaction History

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 612 shares of GH stock, worth $60,061. This represents 0.0% of its overall portfolio holdings.

Number of Shares

612

Previous 278 120.14%

Holding current value

$60,061

Previous $11,000 181.82%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$37.05 - $52.04 $12,374 - $17,381	334 Added 120.14%	612 $31,000
Q1 2025 May 05, 2025	BUY	$31.77 - $49.94 $476 - $749	15 Added 5.7%	278 $11,000
Q4 2024 Feb 04, 2025	BUY	$20.2 - $38.11 $141 - $266	7 Added 2.73%	263 $8,000
Q2 2024 Jul 30, 2024	SELL	$16.07 - $31.84 $51,890 - $102,811	-3,229 Reduced 92.65%	256 $7,000
Q1 2024 Jul 30, 2024	SELL	$17.13 - $26.91 $668 - $1,049	-39 Reduced 1.11%	3,485 $71,000
Q4 2023 Jan 09, 2024	SELL	$21.58 - $29.5 $2,589 - $3,540	-120 Reduced 3.29%	3,524 $95,000
Q3 2023 Oct 12, 2023	BUY	$25.8 - $39.97 $309 - $479	12 Added 0.33%	3,644 $108,000
Q2 2023 Aug 04, 2023	BUY	$20.94 - $38.01 $19,955 - $36,223	953 Added 35.57%	3,632 $130,000
Q1 2023 Apr 18, 2023	BUY	$22.92 - $33.76 $756 - $1,114	33 Added 1.25%	2,679 $62,000
Q4 2022 Feb 07, 2023	SELL	$25.44 - $59.78 $2,849 - $6,695	-112 Reduced 4.06%	2,646 $91,000
Q3 2022 Nov 08, 2022	BUY	$43.66 - $61.0 $51,518 - $71,980	1,180 Added 74.78%	2,758 $100,000
Q2 2022 Sep 06, 2022	BUY	$28.82 - $77.35 $45,477 - $122,058	1,578 New	1,578 $66,000
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $45,477 - $122,058	-1,578 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$48.25 - $100.49 $6,562 - $13,666	136 Added 9.43%	1,578 $104,000
Q1 2022 Aug 08, 2022	BUY	$48.25 - $100.49 $434 - $904	9 Added 0.63%	1,442 $95,000
Q4 2021 Jan 12, 2022	SELL	$88.71 - $120.43 $975 - $1,324	-11 Reduced 0.76%	1,433 $147,000
Q3 2021 Oct 06, 2021	SELL	$98.77 - $132.17 $2,074 - $2,775	-21 Reduced 1.43%	1,444 $184,000
Q2 2021 Jul 13, 2021	SELL	$109.77 - $165.68 $109 - $165	-1 Reduced 0.07%	1,465 $183,000
Q1 2021 Apr 30, 2021	BUY	$127.04 - $179.1 $6,479 - $9,134	51 Added 3.6%	1,466 $226,000
Q4 2020 Jan 25, 2021	BUY	$99.96 - $135.93 $3,698 - $5,029	37 Added 2.69%	1,415 $183,000
Q3 2020 Oct 29, 2020	SELL	$80.32 - $111.8 $1,365 - $1,900	-17 Reduced 1.22%	1,378 $155,000
Q2 2020 Aug 05, 2020	BUY	$60.49 - $97.5 $4,476 - $7,215	74 Added 5.6%	1,395 $113,000
Q1 2020 May 12, 2020	SELL	$59.04 - $88.81 $1,712 - $2,575	-29 Reduced 2.15%	1,321 $93,000
Q4 2019 Jan 17, 2020	BUY	$59.49 - $82.78 $69,305 - $96,438	1,165 Added 629.73%	1,350 $107,000
Q3 2019 Nov 07, 2019	BUY	$62.59 - $110.3 $11,579 - $20,405	185 New	185 $11,000

Others Institutions Holding GH

# of Institutions

429

Shares Held

127M

Call Options Held

1.51M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $10B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account